Literature DB >> 27421843

HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer.

Anne Tuomisto1,2, José García-Solano3,4, Päivi Sirniö5,6, Juha Väyrynen5,6, Miguel Pérez-Guillermo3, Markus J Mäkinen5,6, Pablo Conesa-Zamora7,8.   

Abstract

Serrated colorectal adenocarcinoma (SAC) is a morphologically distinct subtype of colorectal cancer (CRC), in which increased HIF-1α mRNA expression and HIF-1α protein stabilization are typical features. Here we aimed to further elucidate HIF-1α protein expression in serrated and non-serrated colorectal carcinomas (CRCs) and their precursor lesions and its association with vascular endothelial growth factor (VEGF) and microvascular density (MVD). HIF-1α and VEGF expressions were determined immunohistochemically in 134 serrated polyps (SPs), 104 non-serrated adenomas (NSAs), 81 SACs, and 74 matched conventional adenocarcinomas (CCs) and were correlated with morphology, clinicopathological features, and MVD. In premalignant lesions, both HIF-1α and VEGF were expressed in the vast majority of SPs and NSAs. In CRCs, HIF-1α protein was also present in 77.8 % of SACs, while only 20.3 % of CCs were HIF-1α proficient. MVD was significantly higher in SACs, but the serrated morphology was the only significant predictor of MVD in CRC in multivariate analyses. HIF-1α protein is often stabilized in well-vascularized SACs, suggesting hypoxia-independent stabilization of HIF-1α. Moreover, HIF-1α stabilization did not associate with oncogenic activation of BRAF or KRAS or Von Hippel-Lindau (VHL) mutation. Prevalent HIF-1α expression in SAC and its precursors support the importance of HIF-1α-mediated pathways for the serrated route of colorectal carcinogenesis.

Entities:  

Keywords:  Colorectal cancer; HIF-1; Microvessel density; Serrated adenocarcinoma

Mesh:

Substances:

Year:  2016        PMID: 27421843     DOI: 10.1007/s00428-016-1988-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  38 in total

Review 1.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.

Authors:  J R Jass
Journal:  Histopathology       Date:  2007-01       Impact factor: 5.087

2.  Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris
Journal:  J Clin Oncol       Date:  2006-08-08       Impact factor: 44.544

3.  Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma.

Authors:  José García-Solano; Miguel Pérez-Guillermo; Pablo Conesa-Zamora; Jesús Acosta-Ortega; Javier Trujillo-Santos; Pablo Cerezuela-Fuentes; Markus J Mäkinen
Journal:  Hum Pathol       Date:  2010-07-01       Impact factor: 3.466

4.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

Authors:  H Zhong; K Chiles; D Feldser; E Laughner; C Hanrahan; M M Georgescu; J W Simons; G L Semenza
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

Review 5.  Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Trends Pharmacol Sci       Date:  2012-03-06       Impact factor: 14.819

6.  Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.

Authors:  Suresh M Kumar; Hong Yu; Robin Edwards; Lianjun Chen; Steven Kazianis; Patricia Brafford; Geza Acs; Meenhard Herlyn; Xiaowei Xu
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

7.  Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.

Authors:  M Krieg; R Haas; H Brauch; T Acker; I Flamme; K H Plate
Journal:  Oncogene       Date:  2000-11-16       Impact factor: 9.867

Review 8.  Functional regulation of HIF-1α under normoxia--is there more than post-translational regulation?

Authors:  A Kuschel; P Simon; S Tug
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

9.  Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis.

Authors:  Paul G Corn; M Stacey Ricci; Kimberly A Scata; Andrew M Arsham; M Celeste Simon; David T Dicker; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2005-11-07       Impact factor: 4.742

10.  A nontranscriptional role for HIF-1α as a direct inhibitor of DNA replication.

Authors:  Maimon E Hubbi; Daniele M Gilkes; Sergio Rey; Carmen C Wong; Weibo Luo; Deok-Ho Kim; Chi V Dang; Andre Levchenko; Gregg L Semenza
Journal:  Sci Signal       Date:  2013-02-12       Impact factor: 8.192

View more
  5 in total

1.  Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC.

Authors:  Marcela Gonçalves de Souza; Sabrina Ferreira de Jesus; Eloá Mangabeira Santos; Emisael Stenio Batista Gomes; Arlen de Paulo Santiago Filho; Eliane Macedo Sobrinho Santos; Luiz Henrique da Silveira; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Lucyana Conceição Farias; André Luiz Sena Guimarães
Journal:  Pathol Oncol Res       Date:  2018-11-08       Impact factor: 3.201

Review 2.  Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance.

Authors:  Anne E Tuomisto; Markus J Mäkinen; Juha P Väyrynen
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

3.  Hypoxia Inducible Factor-1alpha (HIF-1A) plays different roles in Gallbladder Cancer and Normal Gallbladder Tissues.

Authors:  Youliang Wu; Delong Meng; Yexiang You; Ruochuan Sun; Min Fu; Qiang Yan; Shangxin Zhang; Zheng Fang; Junjun Bao; Yongxiang Li
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

Review 4.  HypoxaMIRs: Key Regulators of Hallmarks of Colorectal Cancer.

Authors:  Jossimar Coronel-Hernández; Izamary Delgado-Waldo; David Cantú de León; César López-Camarillo; Nadia Jacobo-Herrera; Rosalío Ramos-Payán; Carlos Pérez-Plasencia
Journal:  Cells       Date:  2022-06-11       Impact factor: 7.666

Review 5.  Biology and Therapeutic Targets of Colorectal Serrated Adenocarcinoma; Clues for a Histologically Based Treatment against an Aggressive Tumor.

Authors:  Begoña Alburquerque-González; Fernando F López-Calderón; María Dolores López-Abellán; Ángel Esteban-Gil; José García-Solano; Pablo Conesa-Zamora
Journal:  Int J Mol Sci       Date:  2020-03-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.